1. Home
  2. Live Updates
  3. Hans vassg

Page 4 - Hans Vassg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hans vassg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hans Vassg Today - Breaking & Trending Today

Ultimovacs ASA: Invitation to first quarter 2022 results webcast presentation

Ultimovacs ASA: Invitation to first quarter 2022 results webcast presentation Oslo, 5 May 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines ....

Hans Vassg ,

Correction: Ultimovacs ASA: Annual Report 2021

Oslo, 25 March 2021: Ultimovacs ASA ("Ultimovacs", ticker ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces that the Board of Directors of Ultimovacs ASA has approved ....

Hans Vassg , Annual Report , Carlos De Sousa , Chief Executive , European Single Electronic Format , Norwegian Securities Trading ,

Ultimovacs ASA: Fourth quarter 2021 result presentation

Oslo, 17 February 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces its fourth quarter 2021 results today. The presentation ....

Joachim Midttun , Mary Ann Chang , Hans Vassg , Orphan Drug , Fast Track , Although Ultimovacs , Ann Chang , Abuse Regulation , Norwegian Securities Trading , Finance Manager ,

Investegate |Ultimovacs ASA Announcements | Ultimovacs ASA: Ultimovacs Granted Orphan Drug Designation by FDA for UV1 Cancer Vaccine in Metastatic Melanoma

Investegate announcements from Ultimovacs ASA, Ultimovacs Granted Orphan Drug Designation by FDA for UV1 Cancer Vaccine in Metastatic Melanoma ....

Mary Ann Chang , Hans Vassg , Drug Administration , Office Of Orphan Products Development , Ultimovacs Granted Orphan Drug Designation , Metastatic Melanoma , Orphan Products Development , Fast Track , Carlos De Sousa , Ann Chang , Abuse Regulation , Norwegian Securities Trading , Investegate Announcements , Investegate Company Announcements , Ultimovacs Asa , Lobenewswire And Globenewswire ,

Ultimovacs ASA: Ultimovacs Granted Orphan Drug Designation by FDA for UV1 Cancer Vaccine in Metastatic Melanoma

Designation covers UV1 in Metastatic Melanoma as sole agent or part of combinationSeven-year market exclusivity after regulatory approval, if received Oslo, 2 December 2021: Ultimovacs ASA ....

Joachim Midttun , Mary Ann Chang , Hans Vassg , Drug Administration , Office Of Orphan Products Development , Metastatic Melanoma , Orphan Products Development , Fast Track , Carlos De Sousa , Ann Chang , Abuse Regulation , Norwegian Securities Trading , Finance Manager ,